Navigation Links
Rutgers researchers show how the brain can protect against cancer
Date:6/9/2008

New Brunswick, NJ--Scientists have been aware for many years that if cancer patients are not able to deal with the stress associated with being sick, the cancer will progress faster than in calmer patients. To counteract this phenomenon, physicians encourage treatments that help cancer patients handle their stress. Scientists theorized that the stress relief may have come as a result of increased beta-endorphin peptide (BEP), the "feel good" hormones in the brain that are released during exercise, a good conversation, and many other aspects of life that give humans pleasure.

Researchers at Rutgers hypothesized that BEP producing neurons do not just make us feel good, but also play roles in regulating the stress response and immune functions to control tumor growth and progression. In a paper published today in the Proceedings of the National Academy of Science, Dr. Dipak K. Sarkar and his colleagues demonstrate the physical mechanisms that support their hypothesis.

"Our findings show promise for future therapeutic treatments for bolstering the immune function," said Sarkar, professor of animal sciences and director of the Endocrinology Program at the Rutgers School of Environmental and Biological Sciences, and principal investigator of the research project.

Previous research has shown that too few, or inactive, BEP neurons are associated with various diseases. For example, low numbers of BEP neurons have been identified in the brains of patients with depression and schizophrenia. Neurons that produce too little BEP are found in many obese patients. In both these cases the patients also had higher levels of infection and more incidence of cancer.

To test their hypothesis about the role of BEP in controling tumor growth and progression, the Rutgers scientists took neural stem cells, transformed them into BEP neurons by treating them with particular chemicals, and then transplanted them into brains of live rats. The aut
'/>"/>

Contact: Michele Hujber
hujber@aesop.rutgers.edu
732-932-7000
Rutgers University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The Healthcare Foundation of NJ awards grant to Rutgers College of Nursings Rachel Jones
2. 2 Rutgers College of Nursing Ph.D students to receive FNSNA Fellowships
3. Rutgers College of Nursings Linda Flynn to receive N.J. Governors Nursing Merit Award
4. Rutgers research partner Stemcyte, Inc., expands to New Jersey
5. The Zonta Club of Essex County honors Rutgers College of Nursings Rachel Jones
6. Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
7. Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development
8. NJSNA honors Rutgers College of Nursings Linda Flynn for excellence in research
9. Rutgers center sparks liquid bandage, a new frontline wound treatment
10. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
11. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...urn causes demand for affordable drug and alcohol ...a sharp increase in demand for its services and at...s led to an increase in alcoholic binge drinking, ... (PRWEB) December 3, 2009 -- Mountainside... spike in demand for its services due to the econo...
(Date:12/3/2009)...Newswire-USNewswire/ -- The American Association f...from one of the largest studies to date on passive...he Northern California Cancer Center (NCCC) . ,...ed cigarettes and who were exposed to secondhand c...adulthood--had a significantly increased breast ca...
(Date:12/3/2009)...3 For California,s 3.4 million own... remains one of the most significant threats to no...so their business,s viability. ,, "As the rece...wners of small businesses are recognizing the need...ced disability coverage," said Michael Hagedorn, ...
(Date:12/3/2009)...RNewswire/ -- Southern Tier HealthLink NY (STHL) h...a global leader in eHealth technology, to provide ...alth Information Exchange (HIE). ICW will impleme...erprise Master Provider Registry (EMPR) and Integr...sidents, 8 hospitals, and over 800 physicians in c...
(Date:12/3/2009)... the livers of primates , , , THURSDAY,...patitis C has shown promise in a primate study. ,...o prevent the hepatitis C virus from replicating. ...lf, the new DNA-based drug targets a small RNA mol...cate, the researchers explained. , By inhibitin...
Breaking Medicine News(10 mins):Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Southern Tier HealthLink NY Selects InterComponentWare to Deliver Core Components of HIE 2Health News:New Hepatitis C Treatment Shows Promise 2Health News:New Hepatitis C Treatment Shows Promise 3
...that detects and treats cancer cells that are resi...iation showed success in the laboratory and could ...ccording to researchers at SNM,s 55th Annual Meeti...s them unresponsive to most current treatments. , ...
...he SNM 55th Annual Meeting, shows that radioimmuno...vel option to treator even preventmany viral cance...gens or infected cells before they convert into ma...fessor of nuclear medicine and microbiology and im...
...nd red wine, reduces the number of fat cells and m...cording to a new study. The results will be presen... in San Francisco. , Past research found that re...tion. Researchers at the University of Ulm in Germ...
...,WBMD) and HLTH Corporation (Nasdaq: HLTH ) today...to participate at the William Blair 28th Annual,Gr...at 1:30 p.m. ET., Investors, analysts and the gen...om (in the Investor Relations section). A,replay ...
.... (LPI),announced today that it has received tenta...ug Application (ANDA) for Escitalopram Oxalate Tab...dministration (USFDA)., Lupin,s Escitalopram tabl...d product had annual sales of,approximately $2.6 b...
...nth finds that hospitals that perform well on the ...better quality of care than those who,either didn,...o complete,the survey. The study was published in ...ns and,individuals who pay for health care know th...
Other Medicine News:Health News:New therapy shows promise for fighting treatment-resistant cancer cells 2Health News:New study shows potential to treat or prevent viral cancers 2Health News:Red wine's resveratrol may help battle obesity 2Health News:WebMD to Present at the William Blair 28th Annual Growth Stock Conference 2Health News:Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets 2Health News:Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals 2Health News:Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals 3
(Date:12/3/2009)...DFORD, Mass., Dec. 3 MicroCHIPS, a...ems, today announced it has been named a 2010 Tech..., The company was selected for pioneering a novel ...sive implants designed to bridge the gap between d...nologies have broad applicability, from ,rescue, a...
(Date:12/3/2009)..., MAPLE GROVE, Minn., Dec. 3 Upshe...t phase of its strategic plan for central nervous ...e topiramate), an internally developed program for...oped with Upsher-Smith,s proprietary formulation t...l in early 2010 for the adjunctive treatment of ep...
(Date:12/3/2009)...N DIEGO, Dec. 3 Amira Pharmaceut...from a Phase 1 clinical study of AM461, the Compan...lso known as CRTH2) receptor. ,, The interim ...acodynamic (PD) effect can be achieved with AM461....rates a good safety profile. AM461 is a back-up t...
Breaking Medicine Technology:MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum 2Upsher-Smith Announces Milestone in Development of CNS Strategy 2Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2United States Navy And Merchant Marine Veterans May Face Risk Of Mesothelioma Or Other Asbestos Diseases 60212 1United States Navy And Merchant Marine Veterans May Face Risk Of Mesothelioma Or Other Asbestos Diseases 60212 2United States Navy And Merchant Marine Veterans May Face Risk Of Mesothelioma Or Other Asbestos Diseases 60212 3United States Navy And Merchant Marine Veterans May Face Risk Of Mesothelioma Or Other Asbestos Diseases 60212 4New York Merchants Protective Co Designated as Authorized Geutebruck Solutions Provider 60207 1New York Merchants Protective Co Designated as Authorized Geutebruck Solutions Provider 60207 2New York Merchants Protective Co Designated as Authorized Geutebruck Solutions Provider 60207 3Central Blood Bank Offers Twilight Fans a way to be Among First to see the Highly Anticipated Sequel New Moon 60202 1Central Blood Bank Offers Twilight Fans a way to be Among First to see the Highly Anticipated Sequel New Moon 60202 2Central Blood Bank Offers Twilight Fans a way to be Among First to see the Highly Anticipated Sequel New Moon 60202 3
...ike a radio dial, not an on/off,light switch; a di...evelop,late in life, MEMPHIS, Tenn., May 12 A St...at T cells, the body,s master immune,regulators, d...lular,machinery that regulates their development a...lecular controls that enable them to adjust their,...
...ms, Inc.,(OTC Bulletin Board: ABOS) announced toda...U.S. Food and Drug Administration ("FDA") of an,In...e pivotal clinical,trial for SEPET(TM), Arbios, ex...e for blood purification of acutely ill patients s...ased to have received FDA approval to start the SE...
Other Medicine Technology:St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5
...lar is the first HbA1c control available with inta...edure including the lysing of the red blood cell. ...an open-vial stability of 30 days and a closed-via...ellular is appropriate for immunoassay and ionic e...
Siemens Video: Heart of a Soldier
Siemens Webcast: Soarian Disease Management
Siemens Webcast: Legislative Developments Impacting Cardiology Services Reimbursement
Medicine Products: